IMNM: Immunome Inc Sotuvga nisbatan narx
Immunome, Inc. (IMNM) tomonidan maqsadli antitanalarning ishlab chiqilishi, joriy P/S koeffitsienti bilan tasdiqlanganidek, bozor sikllaridan mustaqil qolmoqda. 741.00 qiymati yangi baholash mezonini belgilaydi. Biznes onkologik dori vositalarining bozorga chiqarilishidan oldin hamkorlarning to'lovlariga tayanadi. Xatarlar standart bioxavfli chiqindilarni yo'q qilish nazoratlari bilan cheklangan bo'lib, bu kompaniyaning ekologik muvofiqlikning bazaviy talablariga rioya qilishini ta'minlaydi.
Immunome Corp (IMNM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Immunome Bio|IMNM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunome Corp|IMNM - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Immunome|Tezkor likvidlik ko‘rsatkichi immunome.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
IMNM - Sof foyda|Kutilayotgan sof foyda Immunome, Inc.|IMNM - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Immunome Inc|IMNM - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Immunome Corp|IMNM - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Immunome|IMNM - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi immunome.com|IMNM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Immunome, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:immunome.com (IMNM)
Bozor kapitalizatsiyasining yillik daromadga nisbati aylanma birligi uchun investitsiya qiymatini belgilaydi va biznes qiymatining joriy bozor talqinini aks ettiradi. Immunome, Inc. (IMNM) uchun P/S koeffitsiyenti dinamikasi kompaniyaning baholanishi adekvatligini muhim bosqichlarga erishish sur'atlari va naqd pul sarfining samaradorligiga nisbatan baholash imkonini beradi, bu esa maqsadli konjugatlar ishlab chiqish bosqichidagi biotexnologiya firmasi uchun juda muhimdir.
Immunome, Inc. raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati kiniksa.com|Narxning daromadga nisbati Grifols|Kapitalizatsiyaning daromadga nisbati Adaptive Biotech (ADPT)|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|P/S multiplikatori Aurinia Corp (AUPH)|Narxning daromadga nisbati BioCryst BCRX|VERA: Kapitalizatsiya va daromad nisbati|DNTH - Narxning daromadga nisbati|Sotuvga nisbatan narx Pharvaris NV|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Tourmaline|PGEN (Precigen, Inc.) - P/S multiplikatori|Sotuvga nisbatan narx pharming.com PHAR|Kapitalizatsiyaning daromadga nisbati NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx/daromad koeffitsiyenti Gossamer Bio Corp. (GOSS)|KALV - Narxning daromadga nisbati|SEPN (septerna.com) - Kapitalizatsiya va daromad nisbati|PVLA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Savara Inc|Kapitalizatsiyaning daromadga nisbati RIGL|AnaptysBio Inc. (ANAB) - Narx/daromad koeffitsiyenti|P/S multiplikatori ATXS|Narx/daromad koeffitsiyenti engene.com|Narxning daromadga nisbati RAPT Therapeutics RAPT|JBIO - Kapitalizatsiyaning daromadga nisbati|ACRS - Narxning daromadga nisbati|KYTX (Kyverna Therapeutics, Inc) - Kapitalizatsiya va daromad nisbati|Tiziana Life Sciences (TLSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati cabalettabio.com|Narxning daromadga nisbati Ventyx Biosciences, Inc.|Theratechnologies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AGEN (Agenus)|P/S multiplikatori climbbio.com CLYM|ZURA - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ATYR (aTyr Pharma Inc)|adagene.com (ADAG) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ikena Oncology|STTK (Shattuck Labs Inc) - P/S multiplikatori|P/S multiplikatori Equillium Bio|Kapitalizatsiyaning daromadga nisbati CNTB (Connect Biopharma)|IMUX (immunic-therapeutics.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ATRA (Atara Bio)|Narx/daromad koeffitsiyenti InflaRx NV (IFRX)|XFOR - Narxning daromadga nisbati|Adicet Bio (ACET) - Kapitalizatsiyaning daromadga nisbati|celularity.com (CELU) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati INmune Bio Inc|Kapitalizatsiyaning daromadga nisbati BRNS|P/S multiplikatori Kezar Life Sciences Inc|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|akaritx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Sotuvga nisbatan narx|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|P/S multiplikatori aptevotherapeutics.com (APVO)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI - Narxning daromadga nisbati|Sotuvga nisbatan narx XORTX Therapeutics Inc|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Revelation Biosciences Corp|INDP (Indaptus Therapeutics) - P/S multiplikatori|Sotuvga nisbatan narx scinai.com SCNI|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|AFMD (affimed.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos)|Narx/daromad koeffitsiyenti HOOKIPA Pharma, Inc. (HOOK)|IGMS - Narxning daromadga nisbati|ITOS (iteostherapeutics.com) - Kapitalizatsiya va daromad nisbati|OCEA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|Kapitalizatsiyaning daromadga nisbati THRD
